Summary
First-line combination therapy with aliskiren and amlodipine provided greater reductions in blood pressure (BP) levels and higher rates of BP control compared with amlodipine monotherapy in patients with moderate or severe hypertension, according to new findings from a prospective trial. Combination therapy was also well tolerated, suggesting an important role for aliskiren/amlodipine in the management of patients with type 2 hypertension.
- Hypertensive Disease Clinical Trials
- © 2010 MD Conference Express
Tools
First-Line Treatment with Combination Aliskiren/Amlodipine Improves Blood Pressure Control over Amlodipine Alone in Moderate and Severe Hypertension
Permalink:
Table of contents
Cited By...
- No citing articles found.